COMP Gene Pseudoachondroplasia Genetic Test sale cost 4400 AED
TCIRG1 Gene Osteopetrosis Autosomal Recessive Type 1 Genetic Test sale cost 4400 AED TCIRG1 Gene Osteopetrosis Autosomal Recessive Type 1 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
NOD2 Gene Sarcoidosis Early-Onset Genetic Test sale cost 4400 AED NOD2 Gene Sarcoidosis Early-Onset Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

COMP Gene Pseudoachondroplasia Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The COMP Gene Pseudoachondroplasia Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the COMP gene that are associated with pseudoachondroplasia, a rare genetic disorder. Pseudoachondroplasia is characterized by short stature, abnormal bone growth, and joint abnormalities, which become evident in early childhood. This condition is inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the gene in each cell is sufficient to cause the disorder.

The test involves analyzing the patient’s DNA to look for specific mutations in the COMP gene, which plays a crucial role in the development and maintenance of healthy cartilage and bone. By identifying these mutations, the test can confirm a diagnosis of pseudoachondroplasia, enabling appropriate medical management and genetic counseling for affected individuals and their families.

The cost of the COMP Gene Pseudoachondroplasia Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated nature of the genetic analysis and the specialized expertise required to interpret the results accurately. For families facing the possibility of pseudoachondroplasia, this test provides a crucial step towards understanding their condition and planning for the future.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

COMP Gene Pseudoachondroplasia Genetic Test

Test Name: COMP Gene Pseudoachondroplasia Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for COMP Gene Pseudoachondroplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COMP Gene Pseudoachondroplasia NGS Genetic DNA Test gene COMP

Test Details

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes or even the entire genome. It allows for the rapid and cost-effective analysis of large amounts of genetic data.

In the context of Pseudoachondroplasia, NGS genetic testing can be used to identify mutations in the COMP (Cartilage Oligomeric Matrix Protein) gene. Pseudoachondroplasia is a rare genetic disorder characterized by short stature, joint abnormalities, and early-onset osteoarthritis. It is caused by mutations in the COMP gene, which encodes a protein involved in the formation and maintenance of cartilage.

NGS genetic testing for Pseudoachondroplasia involves sequencing the entire COMP gene or specific regions of interest within the gene. This allows for the detection of various types of mutations, including point mutations, insertions, deletions, and structural rearrangements.

By identifying these mutations, NGS genetic testing can confirm a diagnosis of Pseudoachondroplasia and provide valuable information for genetic counseling and management of the condition.

NGS genetic testing for Pseudoachondroplasia is typically performed using a blood or saliva sample. The DNA from the sample is extracted, and then specific regions of the COMP gene are amplified and sequenced. The resulting sequence data is then analyzed using bioinformatics tools to identify any mutations or genetic variants.

NGS genetic testing has revolutionized the field of genetic testing, allowing for the simultaneous analysis of multiple genes and the detection of rare genetic variants. It offers a more comprehensive and efficient approach to diagnosing genetic disorders like Pseudoachondroplasia. However, it is important to note that NGS genetic testing may not detect all possible mutations, and further confirmatory testing may be required in some cases.

Test Name COMP Gene Pseudoachondroplasia Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for COMP Gene Pseudoachondroplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COMP Gene Pseudoachondroplasia NGS Genetic DNA Test gene COMP
Test Details

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes or even the entire genome. It allows for the rapid and cost-effective analysis of large amounts of genetic data.

In the context of Pseudoachondroplasia, NGS genetic testing can be used to identify mutations in the COMP (Cartilage Oligomeric Matrix Protein) gene. Pseudoachondroplasia is a rare genetic disorder characterized by short stature, joint abnormalities, and early-onset osteoarthritis. It is caused by mutations in the COMP gene, which encodes a protein involved in the formation and maintenance of cartilage.

NGS genetic testing for Pseudoachondroplasia involves sequencing the entire COMP gene or specific regions of interest within the gene. This allows for the detection of various types of mutations, including point mutations, insertions, deletions, and structural rearrangements. By identifying these mutations, NGS genetic testing can confirm a diagnosis of Pseudoachondroplasia and provide valuable information for genetic counseling and management of the condition.

NGS genetic testing for Pseudoachondroplasia is typically performed using a blood or saliva sample. The DNA from the sample is extracted, and then specific regions of the COMP gene are amplified and sequenced. The resulting sequence data is then analyzed using bioinformatics tools to identify any mutations or genetic variants.

NGS genetic testing has revolutionized the field of genetic testing, allowing for the simultaneous analysis of multiple genes and the detection of rare genetic variants. It offers a more comprehensive and efficient approach to diagnosing genetic disorders like Pseudoachondroplasia. However, it is important to note that NGS genetic testing may not detect all possible mutations, and further confirmatory testing may be required in some cases.

SKU: TEST-3222 Category:

Related products